Rep. Cohen Introduces Bill to Modernize How the Government Classifies Controlled Substances
This bill was introduced in the House on June 7, 2026, and sent to the Committee on Energy and Commerce and the Committee on the Judiciary. It is currently waiting for these committees to review it. Since June 7, 2026, no further action has taken place, and most bills do not move past this stage.
This bill faces a difficult path because it changes long-standing drug laws and shifts power away from law enforcement, which often causes disagreement in Congress.
Scores run from -100 (strongly harmful) to +100 (strongly beneficial) for each group, combining impact, certainty, scope, and duration ratings of 1-5. How impact scoring works
If this bill leads to the rescheduling or descheduling of certain substances, it could reduce future criminal exposure for people who use those substances. While it would not retroactively clear anyone's record, a more science-based scheduling framework could mean fewer people face criminal charges for substances that medical experts consider relatively low-risk.
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Sent to a congressional committee for expert review. The committee decides whether this bill moves forward.
Introduced in House
The bill was officially filed and given a number. It now enters the legislative queue.
No votes, news coverage, or related bills recorded for this bill yet.
Document Type
Congressional Bill
Official Title
Controlled Substances Act Clarification in Sciences Act of 2026
Analysis generated by AI. Always verify with official sources.